Abuse-Deterrent Opioids-Evaluation and Labeling
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
April 2, 2015
February 17, 2022
0a716f45-a359-4eab-aacc-8fba6a24447e
Related Documents
Investigational New Drug Applications for Positron Emission Tomography (PET) Drugs
Guidance DocumentDecember 3, 2012Center for Drug Evaluation and Research
Codevelopment of Two or More New Investigational Drugs for Use in Combination
Guidance DocumentJune 14, 2013Center for Drug Evaluation and Research
Submission of Summary Bioequivalence Data for Abbreviated New Drug Applications
Guidance DocumentMay 6, 2011Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.